Polynovo Limited is a limited by shares, listed public company, Australian public company. This corporation was registered on 1998-08-12 and was issued with the 083866862 ACN. Its Australian Business Number is 96083866862. Since 2015-03-19, the company is headquartered in VIC, post code 3207. The previous headquarters were located in VIC 3207 (from 2014-09-13 to 2015-03-19), VIC 3207 (from 2010-09-13 to 2014-09-13), and VIC 3207 (from 2009-01-14 to 2010-09-13). Polynovo Limited was registered for the GST on 2000-07-01. Polynovo Limited has been using the Metabolic Pharmaceuticals Limited trading name since 2012-01-19 until 2016-11-10 (it needs to be noted that the Australian Business Register no longer collects or updates trading names). In total the company used 2 trading names. The above data comes from the ABN database which was updated on 2016-11-11.
| Status | From | To |
|---|---|---|
| Active | April 6, 2000 | current |
| Name | From | To |
|---|---|---|
| Polynovo Limited | November 21, 2014 | current |
| Calzada Limited | February 17, 2010 | November 21, 2014 |
| Metabolic Pharmaceuticals Limited | May 2, 2002 | February 17, 2010 |
| Metabolic Pharmaceuticals Limited | April 6, 2000 | May 2, 2002 |
| Name | From | To |
|---|---|---|
| Metabolic Pharmaceuticals Limited | January 19, 2012 | November 10, 2016 |
| Metabolic Pharmaceuticalslimited | April 6, 2000 | January 19, 2012 |
| Location | From | To |
|---|---|---|
| VIC 3207 | March 19, 2015 | current |
| VIC 3207 | September 13, 2014 | March 19, 2015 |
| VIC 3207 | September 13, 2010 | September 13, 2014 |
| VIC 3207 | January 14, 2009 | September 13, 2010 |
| VIC 3004 | February 9, 2004 | January 14, 2009 |
| VIC 3142 | April 6, 2000 | February 9, 2004 |
| Status | From | To |
|---|---|---|
| Registered | July 1, 2000 | current |
Advertisements
General information:
| Patent status: |
Lapsed Either the application has not been accepted by 21 months after the first examination report (or 12 months after the Raising the Bar Act) or some other deadline in the prosecution process has not been completed in time, for example IP Australia has issued a direction to file a request for examination and the applicant has not done so in the required period (2 months). |
| Patent type: | NPE |
International Patent Classification:
| IPC Mark: | A61P 25/26 |
| Section code: | A - human necessities |
| Class code: | 61 - medical or veterinary science; hygiene |
| Subclass code: | P - specific therapeutic activity of chemical compounds or medicinal preparations |
| Main group code: | 25 - drugs for disorders of the nervous system |
| Subgroup code: | 26 - psychostimulants, e.g. nicotine, cocaine |
IP Australia process information:
| Expiry date: | May 2, 2023 |
International Patent Classification:
| IPC Mark: | C07K 14/61 |
| Section code: | C - chemistrymetallurgy |
| Class code: | 7 - organic chemistry |
| Subclass code: | K - peptides (peptides containing -lactam rings c07d; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d; ergot alkaloids of the cyclic peptide type c07d0519020000; genetic engineering processes for obtaining peptides c12n0015000000) |
| Main group code: | 14 - peptides having more than 20 amino acids; gastrins; somatostatins; melanotropins; derivatives thereof |
| Subgroup code: | 61 - growth hormone (gh) (somatotropin) |
IP Australia process information:
| Expiry date: | September 4, 2018 |
General information:
| Patent status: |
Lapsed Either the application has not been accepted by 21 months after the first examination report (or 12 months after the Raising the Bar Act) or some other deadline in the prosecution process has not been completed in time, for example IP Australia has issued a direction to file a request for examination and the applicant has not done so in the required period (2 months). |
| Patent type: | STANDARD |
International Patent Classification:
| IPC Mark: | C07K 7/08 |
| Section code: | C - chemistrymetallurgy |
| Class code: | 7 - organic chemistry |
| Subclass code: | K - peptides (peptides containing -lactam rings c07d; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d; ergot alkaloids of the cyclic peptide type c07d0519020000; genetic engineering processes for obtaining peptides c12n0015000000) |
| Main group code: | 7 - peptides having 5 to 20 amino acids in a fully defined sequence; derivatives thereof |
| Subgroup code: | 8 - having 12 to 20 amino acids |
IP Australia process information:
| Expiry date: | September 4, 2018 |
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.